Skip to main content
Fig. 4 | BMC Ophthalmology

Fig. 4

From: Demographics of patients receiving Intravitreal anti-VEGF treatment in real-world practice: healthcare research data versus randomized controlled trials

Fig. 4

Baseline visual acuity distribution in OCEAN and visual acuity for OCEAN and RCTs, by indication. Legend: Visual acuity distribution in ETDRS letter analogues by group for OCEAN and mean visual acuity (in ETDRS letter analogues with SD) for OCEAN and RCTs. Mean visual acuity is given overall per study (black square) and as mean with SD for each individual treatment group (grey circles with error bars). If the mean was not available, the median is shown (grey square) with 25th/75th percentiles. The data for the individual treatment groups of each RCT are shown in the same order from top to bottom as the treatment groups are presented in Tables 2, 3, 4. aThe visual acuity results for SAILOR are provided for four treatment groups. bData provided as median (25th, 75th percentile). c Data provided for number of eyes, not number of patients. Abbreviations: BRVO: branch retinal vein occlusion; CRVO: central retinal vein occlusion; DME: diabetic macular oedema; ETDRS: Early Treatment Diabetic Retinopathy Study; nAMD: neovascular age-related macular degeneration; RCT: randomized controlled trial; SD: standard deviation

Back to article page

BMC Ophthalmology

ISSN: 1471-2415

Contact us